nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclizine—SULT1E1—adrenal cortex—polycystic ovary syndrome	0.0539	0.19	CbGeAlD
Cyclizine—SULT1E1—adrenal gland—polycystic ovary syndrome	0.0389	0.137	CbGeAlD
Cyclizine—CYP2C9—urine—polycystic ovary syndrome	0.0369	0.13	CbGeAlD
Cyclizine—SULT1E1—female gonad—polycystic ovary syndrome	0.0362	0.128	CbGeAlD
Cyclizine—SULT1E1—vagina—polycystic ovary syndrome	0.036	0.127	CbGeAlD
Cyclizine—SULT1E1—endocrine gland—polycystic ovary syndrome	0.0337	0.119	CbGeAlD
Cyclizine—HRH1—endometrium—polycystic ovary syndrome	0.0086	0.0303	CbGeAlD
Cyclizine—HRH1—adipose tissue—polycystic ovary syndrome	0.00775	0.0273	CbGeAlD
Cyclizine—HRH1—adrenal gland—polycystic ovary syndrome	0.00695	0.0245	CbGeAlD
Cyclizine—HRH1—female gonad—polycystic ovary syndrome	0.00648	0.0228	CbGeAlD
Cyclizine—HRH1—vagina—polycystic ovary syndrome	0.00644	0.0227	CbGeAlD
Cyclizine—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00611	0.0215	CbGeAlD
Cyclizine—HRH1—endocrine gland—polycystic ovary syndrome	0.00603	0.0212	CbGeAlD
Cyclizine—Bifonazole—CYP17A1—polycystic ovary syndrome	0.00594	0.149	CrCbGaD
Cyclizine—Modafinil—ADRA1B—polycystic ovary syndrome	0.00425	0.107	CrCbGaD
Cyclizine—Phenoxybenzamine—ADRA1D—polycystic ovary syndrome	0.00413	0.104	CrCbGaD
Cyclizine—Phenoxybenzamine—ADRA1B—polycystic ovary syndrome	0.00352	0.0883	CrCbGaD
Cyclizine—Bifonazole—CYP19A1—polycystic ovary syndrome	0.00302	0.0757	CrCbGaD
Cyclizine—Loxapine—ADRA1B—polycystic ovary syndrome	0.00284	0.0712	CrCbGaD
Cyclizine—Benzphetamine—ADRA1A—polycystic ovary syndrome	0.00248	0.0622	CrCbGaD
Cyclizine—Clozapine—ADRA1B—polycystic ovary syndrome	0.00239	0.0598	CrCbGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PTAFR—polycystic ovary syndrome	0.00238	0.00352	CbGpPWpGaD
Cyclizine—Phenoxybenzamine—ADRA1A—polycystic ovary syndrome	0.00237	0.0595	CrCbGaD
Cyclizine—SULT1E1—Metabolism—STAR—polycystic ovary syndrome	0.00234	0.00345	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1D—polycystic ovary syndrome	0.00231	0.00342	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPB—polycystic ovary syndrome	0.00226	0.00334	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1B—polycystic ovary syndrome	0.00225	0.00333	CbGpPWpGaD
Cyclizine—CYP2C9—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.00224	0.00331	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—PTGER3—polycystic ovary syndrome	0.0022	0.00326	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—LHCGR—polycystic ovary syndrome	0.0022	0.00326	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—HMMR—polycystic ovary syndrome	0.00208	0.00308	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—PTAFR—polycystic ovary syndrome	0.00206	0.00304	CbGpPWpGaD
Cyclizine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00205	0.00303	CbGpPWpGaD
Cyclizine—CYP2C9—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.00202	0.00299	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA1D—polycystic ovary syndrome	0.002	0.00296	CbGpPWpGaD
Cyclizine—HRH1—IL-4 Signaling Pathway—IRS2—polycystic ovary syndrome	0.00199	0.00294	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—HSD3B1—polycystic ovary syndrome	0.00199	0.00294	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA1B—polycystic ovary syndrome	0.00194	0.00288	CbGpPWpGaD
Cyclizine—CYP2C9—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00192	0.00283	CbGpPWpGaD
Cyclizine—Loxapine—ADRA1A—polycystic ovary syndrome	0.00191	0.0479	CrCbGaD
Cyclizine—HRH1—G alpha (q) signalling events—ADRA1A—polycystic ovary syndrome	0.00191	0.00282	CbGpPWpGaD
Cyclizine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.0019	0.00281	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGER3—polycystic ovary syndrome	0.00189	0.00279	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—LHCGR—polycystic ovary syndrome	0.00189	0.00279	CbGpPWpGaD
Cyclizine—CYP2C9—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00188	0.00278	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—LHB—polycystic ovary syndrome	0.00181	0.00268	CbGpPWpGaD
Cyclizine—Flunarizine—CYP1A1—polycystic ovary syndrome	0.00179	0.0448	CrCbGaD
Cyclizine—HRH1—G alpha (q) signalling events—GNRH1—polycystic ovary syndrome	0.00177	0.00262	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—HSD3B2—polycystic ovary syndrome	0.00177	0.00262	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTAFR—polycystic ovary syndrome	0.00176	0.00261	CbGpPWpGaD
Cyclizine—HRH1—IL-4 Signaling Pathway—IRS1—polycystic ovary syndrome	0.00174	0.00257	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—NPB—polycystic ovary syndrome	0.00172	0.00254	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—AKR1C1—polycystic ovary syndrome	0.00171	0.00254	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.00171	0.00253	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1A—polycystic ovary syndrome	0.0017	0.00252	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.00167	0.00246	CbGpPWpGaD
Cyclizine—CYP2C9—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00166	0.00245	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.00161	0.00238	CbGpPWpGaD
Cyclizine—Clozapine—ADRA1A—polycystic ovary syndrome	0.00161	0.0402	CrCbGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—polycystic ovary syndrome	0.00158	0.00234	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—SULT2A1—polycystic ovary syndrome	0.00158	0.00233	CbGpPWpGaD
Cyclizine—CYP2C9—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00154	0.00228	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—RRM2—polycystic ovary syndrome	0.00153	0.00226	CbGpPWpGaD
Cyclizine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00151	0.00223	CbGpPWpGaD
Cyclizine—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00149	0.0022	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.00147	0.00218	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—YAP1—polycystic ovary syndrome	0.00147	0.00218	CbGpPWpGaD
Cyclizine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00144	0.00214	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00144	0.00212	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.00144	0.00212	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.00142	0.0021	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—NAMPT—polycystic ovary syndrome	0.00142	0.00209	CbGpPWpGaD
Cyclizine—Cinnarizine—CYP1A1—polycystic ovary syndrome	0.00141	0.0354	CrCbGaD
Cyclizine—Phenoxybenzamine—ADRB2—polycystic ovary syndrome	0.00141	0.0354	CrCbGaD
Cyclizine—CYP2C9—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.0014	0.00208	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—CYP11A1—polycystic ovary syndrome	0.0014	0.00207	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00138	0.00204	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00134	0.00199	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—AKR1C3—polycystic ovary syndrome	0.00132	0.00195	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.0013	0.00193	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—CYP17A1—polycystic ovary syndrome	0.0013	0.00192	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00127	0.00188	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00126	0.00187	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00125	0.00185	CbGpPWpGaD
Cyclizine—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00122	0.0018	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00122	0.0018	CbGpPWpGaD
Cyclizine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00121	0.00179	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.0012	0.00178	CbGpPWpGaD
Cyclizine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.0012	0.00177	CbGpPWpGaD
Cyclizine—HRH1—G alpha (q) signalling events—GHRL—polycystic ovary syndrome	0.0012	0.00177	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00117	0.00174	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—TH—polycystic ovary syndrome	0.00112	0.00166	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—SLC2A4—polycystic ovary syndrome	0.00109	0.00162	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00107	0.00159	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—polycystic ovary syndrome	0.00107	0.00158	CbGpPWpGaD
Cyclizine—CYP2C9—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00107	0.00158	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00105	0.00155	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—CYP19A1—polycystic ovary syndrome	0.00103	0.00152	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000995	0.00147	CbGpPWpGaD
Cyclizine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000984	0.00145	CbGpPWpGaD
Cyclizine—CYP2C9—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000981	0.00145	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.000972	0.00144	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.000961	0.00142	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000944	0.0014	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000925	0.00137	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—GNAS—polycystic ovary syndrome	0.000918	0.00136	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000914	0.00135	CbGpPWpGaD
Cyclizine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000905	0.00134	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000894	0.00132	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000883	0.00131	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000881	0.0013	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000879	0.0013	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—NCOR1—polycystic ovary syndrome	0.000874	0.00129	CbGpPWpGaD
Cyclizine—CYP2C9—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000869	0.00129	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000861	0.00127	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000861	0.00127	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000857	0.00127	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000829	0.00123	CbGpPWpGaD
Cyclizine—CYP2C9—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000821	0.00121	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000819	0.00121	CbGpPWpGaD
Cyclizine—Clozapine—CYP1A1—polycystic ovary syndrome	0.000819	0.0205	CrCbGaD
Cyclizine—HRH1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000817	0.00121	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000812	0.0012	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000812	0.0012	CbGpPWpGaD
Cyclizine—CYP2C9—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000808	0.00119	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000799	0.00118	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000793	0.00117	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—MTHFR—polycystic ovary syndrome	0.000773	0.00114	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.000766	0.00113	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000759	0.00112	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000746	0.0011	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000746	0.0011	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000737	0.00109	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000737	0.00109	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000737	0.00109	CbGpPWpGaD
Cyclizine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000733	0.00108	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000717	0.00106	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000689	0.00102	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000669	0.00099	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000656	0.00097	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000652	0.000965	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000651	0.000963	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000648	0.000959	CbGpPWpGaD
Cyclizine—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000639	0.000945	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—PPARG—polycystic ovary syndrome	0.000626	0.000927	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000625	0.000925	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—POMC—polycystic ovary syndrome	0.000618	0.000914	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—INS—polycystic ovary syndrome	0.000614	0.000909	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000604	0.000893	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000597	0.000883	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000594	0.000878	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000593	0.000877	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000592	0.000876	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000565	0.000836	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000543	0.000803	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000539	0.000798	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000523	0.000773	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000522	0.000773	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NPB—polycystic ovary syndrome	0.000522	0.000771	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000517	0.000764	CbGpPWpGaD
Cyclizine—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000515	0.000762	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000505	0.000747	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.0005	0.000739	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000493	0.00073	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000484	0.000716	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000481	0.000711	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000475	0.000702	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000472	0.000698	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000469	0.000694	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000463	0.000685	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000462	0.000683	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	0.00046	0.00068	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000459	0.000678	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00044	0.00065	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000438	0.000648	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000435	0.000644	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000435	0.000644	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000429	0.000634	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	0.00042	0.000622	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	0.00042	0.000622	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000419	0.00062	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000415	0.000614	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.00041	0.000606	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000407	0.000602	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000395	0.000585	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000391	0.000578	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.00039	0.000576	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000385	0.000569	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000382	0.000565	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000375	0.000554	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000357	0.000527	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00035	0.000517	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000341	0.000505	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000338	0.0005	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.000332	0.000491	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000332	0.000491	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000319	0.000473	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000319	0.000471	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000315	0.000465	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000312	0.000461	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00031	0.000458	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.0003	0.000443	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000291	0.000431	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FST—polycystic ovary syndrome	0.000284	0.00042	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000282	0.000418	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000281	0.000415	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.000278	0.000412	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000277	0.00041	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000271	0.000401	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000264	0.00039	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000262	0.000388	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000262	0.000387	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SCT—polycystic ovary syndrome	0.00026	0.000384	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000256	0.000379	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	0.000252	0.000372	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000249	0.000368	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000248	0.000366	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000244	0.00036	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000241	0.000357	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.00024	0.000356	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000238	0.000352	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000225	0.000333	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	0.000224	0.000332	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000222	0.000329	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	0.000214	0.000317	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000213	0.000314	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000212	0.000313	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000202	0.000299	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000201	0.000297	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000199	0.000294	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000197	0.000291	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	0.000195	0.000289	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	0.000191	0.000282	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	0.000185	0.000273	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000183	0.000271	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000183	0.000271	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000176	0.000261	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000175	0.000258	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00017	0.000252	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	0.00017	0.000252	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000169	0.000251	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	0.000165	0.000244	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000161	0.000238	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.00016	0.000237	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PRL—polycystic ovary syndrome	0.00016	0.000236	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	0.000159	0.000235	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000154	0.000228	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	0.000153	0.000226	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000152	0.000224	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000151	0.000224	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	0.000151	0.000223	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.00015	0.000221	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	0.000142	0.00021	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.00014	0.000208	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	0.00014	0.000207	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000134	0.000198	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000131	0.000194	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—TH—polycystic ovary syndrome	0.000121	0.000179	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	0.000118	0.000174	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000113	0.000166	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	0.000111	0.000164	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—LEP—polycystic ovary syndrome	0.00011	0.000163	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	9.89e-05	0.000146	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IRS1—polycystic ovary syndrome	9.82e-05	0.000145	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—POMC—polycystic ovary syndrome	9.46e-05	0.00014	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	9.43e-05	0.000139	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—INS—polycystic ovary syndrome	9.41e-05	0.000139	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IGF1—polycystic ovary syndrome	9.1e-05	0.000135	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AKT2—polycystic ovary syndrome	9.09e-05	0.000134	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	8.93e-05	0.000132	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.64e-05	0.000128	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	8.33e-05	0.000123	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—IL6—polycystic ovary syndrome	6.96e-05	0.000103	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	6.75e-05	9.99e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	6.66e-05	9.85e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—INS—polycystic ovary syndrome	6.62e-05	9.8e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.94e-05	8.79e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IL6—polycystic ovary syndrome	4.11e-05	6.08e-05	CbGpPWpGaD
